Michael Mackett

1.0k total citations
13 papers, 779 citations indexed

About

Michael Mackett is a scholar working on Epidemiology, Genetics and Oncology. According to data from OpenAlex, Michael Mackett has authored 13 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 5 papers in Genetics and 4 papers in Oncology. Recurrent topics in Michael Mackett's work include Virus-based gene therapy research (5 papers), Herpesvirus Infections and Treatments (5 papers) and Viral-associated cancers and disorders (4 papers). Michael Mackett is often cited by papers focused on Virus-based gene therapy research (5 papers), Herpesvirus Infections and Treatments (5 papers) and Viral-associated cancers and disorders (4 papers). Michael Mackett collaborates with scholars based in United Kingdom, United States and Switzerland. Michael Mackett's co-authors include Bernard Moss, Geoffrey L. Smith, Kenneth J. Cremer, Charles Wohlenberg, Abner Louis Notkins, Manfred Schulz, David H.L. Bishop, Rolf M. Zinkernagel, Hans Hengartner and Stephan Oehen and has published in prestigious journals such as Nature, Science and The Journal of Infectious Diseases.

In The Last Decade

Michael Mackett

13 papers receiving 706 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Mackett United Kingdom 11 414 282 239 236 169 13 779
J. F. Kaye United Kingdom 10 504 1.2× 271 1.0× 161 0.7× 244 1.0× 284 1.7× 10 810
Kenneth J. Cremer United States 12 461 1.1× 437 1.5× 196 0.8× 333 1.4× 237 1.4× 16 900
Sandra Silver United States 13 569 1.4× 338 1.2× 210 0.9× 185 0.8× 331 2.0× 20 976
Roderick I. Macfarlan Australia 13 404 1.0× 204 0.7× 232 1.0× 575 2.4× 217 1.3× 17 947
Paul P. Hung Canada 16 416 1.0× 313 1.1× 125 0.5× 120 0.5× 245 1.4× 30 857
Vincent P. Smith United Kingdom 11 467 1.1× 126 0.4× 340 1.4× 239 1.0× 220 1.3× 12 882
C Pachl United States 18 922 2.2× 275 1.0× 265 1.1× 414 1.8× 304 1.8× 21 1.5k
Kenichi Umene Japan 19 752 1.8× 179 0.6× 152 0.6× 298 1.3× 121 0.7× 61 1.1k
Valerie G. Preston United Kingdom 17 1.1k 2.7× 343 1.2× 206 0.9× 236 1.0× 175 1.0× 20 1.2k
S. K. Vernon United States 14 398 1.0× 193 0.7× 112 0.5× 126 0.5× 153 0.9× 24 600

Countries citing papers authored by Michael Mackett

Since Specialization
Citations

This map shows the geographic impact of Michael Mackett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Mackett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Mackett more than expected).

Fields of papers citing papers by Michael Mackett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Mackett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Mackett. The network helps show where Michael Mackett may publish in the future.

Co-authorship network of co-authors of Michael Mackett

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Mackett. A scholar is included among the top collaborators of Michael Mackett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Mackett. Michael Mackett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Mackett, Michael. (2003). Manipulation of Vaccinia Virus Vectors. Humana Press eBooks. 7. 129–146. 1 indexed citations
2.
Jenson, Hal B., Yasmin Ench, Yan‐Jin Zhang, et al.. (2002). Characterization of an Epstein–Barr virus-related gammaherpesvirus from common marmoset (Callithrix jacchus). Journal of General Virology. 83(7). 1621–1633. 13 indexed citations
3.
Tan, Peng, William J. King, Daxin Chen, et al.. (2001). TRANSFERRIN RECEPTOR-MEDIATED GENE TRANSFER TO THE CORNEAL ENDOTHELIUM1. Transplantation. 71(4). 552–560. 39 indexed citations
4.
Jenson, Hal B., Yasmin Ench, Shou‐Jiang Gao, et al.. (2000). Epidemiology of Herpesvirus Papio Infection in a Large Captive Baboon Colony: Similarities to Epstein‐Barr Virus Infection in Humans. The Journal of Infectious Diseases. 181(4). 1462–1466. 19 indexed citations
5.
Malin, Adam, Kris Huygen, Jean Content, et al.. (2000). Vaccinia expression of secreted proteins: tissue plasminogen activator signal sequence enhances expression and immunogenicity of Ag85. Microbes and Infection. 2(14). 1677–1685. 21 indexed citations
6.
Bennett, Alice M., et al.. (1999). Recombinant Vaccinia Viruses Protect Against Clostridium perfringens α-Toxin. Viral Immunology. 12(2). 97–105. 21 indexed citations
7.
Stacey, Simon, A K Ghosh, Jennifer S. Bartholomew, et al.. (1993). Expression of human papillomavirus type 16 E7 protein by recombinant baculovirus and use for the detection of E7 antibodies in sera from cervical carcinoma patients. Journal of Medical Virology. 40(1). 14–21. 13 indexed citations
8.
Lee, Steven P., Lesley E. Wallace, Michael Mackett, et al.. (1993). MHC class II-restricted presentation of endogenously synthesized antigen: Epstein-Barr virus transformed B cell lines can present the viral glycoprotein gp340 by two distinct pathways. International Immunology. 5(5). 451–460. 9 indexed citations
9.
Lees, Janice F., et al.. (1993). The Epstein-Barr Virus Candidate Vaccine Antigen gp340/220 Is Highly Conserved between Virus Types A and B. Virology. 195(2). 578–586. 18 indexed citations
10.
11.
Cremer, Kenneth J., Michael Mackett, Charles Wohlenberg, Abner Louis Notkins, & Bernard Moss. (1985). Vaccinia Virus Recombinant Expressing Herpes Simplex Virus Type 1 Glycoprotein D Prevents Latent Herpes in Mice. Science. 228(4700). 737–740. 170 indexed citations
12.
Smith, Geoffrey L., Michael Mackett, & Bernard Moss. (1984). Recombinant Vaccinia Viruses as New Live Vaccines. Biotechnology and Genetic Engineering Reviews. 2(1). 383–407. 17 indexed citations
13.
Smith, Geoffrey L., Michael Mackett, & Bernard Moss. (1983). Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen. Nature. 302(5908). 490–495. 330 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. F. Kaye Breakdown of academic impact, for papers by Kenneth J. Cremer Breakdown of academic impact, for papers by Sandra Silver Breakdown of academic impact, for papers by Roderick I. Macfarlan Breakdown of academic impact, for papers by Paul P. Hung Breakdown of academic impact, for papers by Vincent P. Smith Breakdown of academic impact, for papers by C Pachl Breakdown of academic impact, for papers by Kenichi Umene Breakdown of academic impact, for papers by Valerie G. Preston Breakdown of academic impact, for papers by S. K. Vernon
Rankless by CCL
2026